glp-1 gastroparesis law firm in michigan office Wegovy Lawsuit Over Gastroparesis GLP-1 Lawsuits: What to Know

Increasing scientific data on the obesity-pancreatic diseases conundrum also necessitates the need for integrating obesity-related markers into risk stratification and prognostic models, as well as exploring targeted therapeutic strategies in obesity-associated pancreatic disease.

Learn how to manage and chart GLP-1 protocols like semaglutide and tirzepatide in your EHR, including documentation, labs, scheduling, and billing workflows.

alli (orlistat 60 milligram capsules) is a weight loss aid for overweight adults, 18 years and older, when used along with a reduced calorie and low fat diet

Our doctors and clinicians are with you every step of the journey.

In 5 years, obesity drugs went from 15% weight loss (Wegovy) to 29% (Retatrutide)